Page last updated: 2024-11-03

prazosin and Movement Disorders

prazosin has been researched along with Movement Disorders in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shliakhto, EV1
Nedogoda, SV1
Nifontov, EM1
Pushkarev, AA1
Savushkin, SN1

Other Studies

1 other study available for prazosin and Movement Disorders

ArticleYear
[A case of intolerance to the adrenergic alpha1 blockader prazosin].
    Klinicheskaia meditsina, 1988, Volume: 66, Issue:11

    Topics: Affective Symptoms; Humans; Hypotension, Orthostatic; Male; Middle Aged; Movement Disorders; Prazosi

1988